Company: BIAF
Filing Date: 2025-04-11
Form Type: S-1
Source: 0001641172-25-003892
Chunk: 76

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-04-11
Form: S-1
Chunk 76
---
 Preferred Stock may be issued from time to time in one or more series, each of which shall have a distinctive
designation or title as is determined by our Board prior to the issuance of any shares thereof. The Preferred Stock may have such voting
powers, full, enhanced or limited, or no voting powers, and such preferences and relative, participating, optional, or other special rights
and such qualifications, limitations, or restrictions thereof as adopted by the Board, which may include enhanced dividend rights, rights
of redemption, sinking funds to pay dividends, liquidation, and other rights that would be different than, and preferential to, the rights
of the Common Stockholders. Because our Board is able to designate the powers and preferences of the Preferred Stock without the vote
of a majority of our stockholders, Common Stockholders will have no control over what designations and preferences our Preferred Stock
will have. If Preferred Stock is designated and issued, then depending upon the designation and preferences, the holders of the Preferred
Stock may exercise voting control. As a result, our stockholders would have no control over the operations of our Company.

Provisions in our corporate charter documents and under Delaware law could make an acquisition of the Company, which may be beneficial to our stockholders, more difficult and may prevent attempts by our stockholders to replace or remove our current management.

Provisions in our certificate of incorporation, as
amended (our “Charter”) and amended and restated bylaws (“A&R Bylaws”) may discourage, delay, or prevent a
merger, acquisition, or other change in control, that stockholders may consider favorable, including transactions in which you might otherwise
receive a premium for your shares. These provisions also could limit the price that investors might be willing to pay in the future for
shares of our Common Stock, thereby depressing the market price of our Common Stock. In addition, because our Board is responsible for
appointing the members of our management team, these provisions may frustrate or prevent any attempts by our stockholders to replace or
remove our current management by making it more difficult for stockholders to replace members of our Board. Among other things, these
provisions:

| ● | allow the authorized number of our directors to be changed only by resolution of our Board;                                                         |
| ● | establish advance notice requirements for stockholder proposals that can be acted on at stockholder meetings and nominations to our Board;          |
| ● | require that stockholder actions must be effected at a duly called